Ocular Therapeutix™ Reports Fourth Quarter and Full Year 2016 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. RNG
2. WDC
3. DECK
4. BYD
5. WCN
6. SPOT
7. FIX
8. TSCO
9. BE
10. SLM

Go back to Ocular Therapeutix™ Reports Fourth Quarter and Full Year 2016 Financial Results

Ocular Therapeutix (OCUL) Misses Q4 EPS by 7c

March 10, 2017 7:34 AM EST

Ocular Therapeutix (NASDAQ: OCUL) reported Q4 EPS of ($0.52), $0.07 worse than the analyst estimate of ($0.45).

PDUFA Target Action Date of July 19, 2017 for the DEXTENZA NDA for the Treatment of Ocular Pain Occurring After Ophthalmic Surgery

For earnings history and earnings-related data on Ocular Therapeutix (OCUL) click here.

... More